TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells P Rosenstiel, M Fantini, K Bräutigam, T Kühbacher, GH Waetzig, ... Gastroenterology 124 (4), 1001-1009, 2003 | 557 | 2003 |
S3-Guideline „Colorectal Cancer “2004/2008 W Schmiegel, C Pox, A Reinacher-Schick, G Adler, W Fleig, UR Fölsch, ... Z Gastroenterol 46, 1-73, 2008 | 491* | 2008 |
Fungi and inflammatory bowel diseases: alterations of composition and diversity SJ Ott, T Kühbacher, M Musfeldt, P Rosenstiel, S Hellmig, A Rehman, ... Scandinavian journal of gastroenterology 43 (7), 831-841, 2008 | 479 | 2008 |
Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease SJ Ott, NE El Mokhtari, M Musfeldt, S Hellmig, S Freitag, A Rehman, ... Circulation 113 (7), 929-937, 2006 | 470 | 2006 |
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial CSJ Probert, SD Hearing, S Schreiber, T Kühbacher, S Ghosh, IDR Arnott, ... Gut 52 (7), 998-1002, 2003 | 469 | 2003 |
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo … S Vermeire, S Schreiber, R Petryka, T Kuehbacher, X Hebuterne, ... The Lancet 389 (10066), 266-275, 2017 | 467 | 2017 |
S3-Leitlinie „Kolorektales Karzinom “–Aktualisierung 2008. Ergebnis einer evidenzbasierten Konsensuskonferenz (8.–9. Juni 2007) W Schmiegel, A Reinacher-Schick, D Arnold, U Graeven, V Heinemann, ... Z gastroenterol 46 (8), 799-840, 2008 | 355 | 2008 |
S3-Leitlinie „Kolorektales Karzinom “-Ergebnisse evidenzbasierter Konsensuskonferenzen am 6./7. Februar 2004 und am 8./9 W Schmiegel, C Pox, A Reinacher-Schick, G Adler, W Fleig, UR Fölsch, ... Juni, 2007 | 355* | 2007 |
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104: H4 induced haemolytic uraemic syndrome: case-control study J Menne, M Nitschke, R Stingele, M Abu-Tair, J Beneke, J Bramstedt, ... BMJ: British Medical Journal 345, 2012 | 346 | 2012 |
Bacterial and fungal microbiota in relation to probiotic therapy (VSL# 3) in pouchitis T Kuehbacher, SJ Ott, U Helwig, T Mimura, F Rizzello, B Kleessen, ... Gut 55 (6), 833-841, 2006 | 322 | 2006 |
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease S Schreiber, P Rosenstiel, J Hampe, S Nikolaus, B Groessner, ... Gut 51 (3), 379-385, 2002 | 247 | 2002 |
Efficacy and safety of etrasimod in a phase 2 randomized trial of patients with ulcerative colitis WJ Sandborn, L Peyrin-Biroulet, J Zhang, M Chiorean, S Vermeire, ... Gastroenterology 158 (3), 550-561, 2020 | 201 | 2020 |
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice–a nationwide consecutive German cohort study DC Baumgart, B Bokemeyer, A Drabik, A Stallmach, S Schreiber, ... Alimentary pharmacology & therapeutics 43 (10), 1090-1102, 2016 | 198 | 2016 |
Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease T Kuehbacher, A Rehman, P Lepage, S Hellmig, UR Fölsch, S Schreiber, ... Journal of medical microbiology 57 (12), 1569-1576, 2008 | 194 | 2008 |
A comparison of oligonucleotide and cDNA-based microarray systems N Mah, A Thelin, T Lu, S Nikolaus, T Kühbacher, Y Gurbuz, H Eickhoff, ... Physiological genomics 16 (3), 361-370, 2004 | 183 | 2004 |
Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab S Mascheretti, J Hampe, T Kühbacher, H Herfarth, M Krawczak, ... The pharmacogenomics journal 2 (2), 127-136, 2002 | 183 | 2002 |
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease S Schreiber, K Aden, JP Bernardes, C Conrad, F Tran, H Höper, V Volk, ... Gastroenterology 160 (7), 2354-2366. e11, 2021 | 174 | 2021 |
Mechanisms in failure of infliximab for Crohn's disease S Nikolaus, A Raedler, T Kühbacher, N Sfikas, UR Fölsch, S Schreiber The Lancet 356 (9240), 1475-1479, 2000 | 166 | 2000 |
S3-Leitlinienkonferenz W Schmiegel, C Pox, G Adler, W Fleig, UR Fölsch, P Frühmorgen, ... DMW-Deutsche Medizinische Wochenschrift 130 (S 1), S5-S53, 2005 | 163* | 2005 |
S3-Leitlinienkonferenz „Kolorektales Karzinom “2004 W Schmiegel, C Pox, G Adler, W Fleig, UR Fölsch, P Frühmorgen, ... Z Gastroenterol 42 (10), 1129-1177, 2004 | 163* | 2004 |